IMPACT Biotech Ltd
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 2003-02-13
- Employees
- -
- Market Cap
- -
- Website
- https://impact.pub/
Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
Phase 1
Recruiting
- Conditions
- Locally Advanced Unresectable Pancreatic Adenocarcinoma
- Interventions
- Combination Product: Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Impact Biotech Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT05919238
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸University of California Irvine, Irvine, California, United States
Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer
Phase 1
Recruiting
- Conditions
- Peripheral Lung Tumor
- Interventions
- Combination Product: Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Impact Biotech Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT05918783
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath